Use of human liver and EpiSkin™ S9 subcellular fractions as a screening assays to compare the in vitro hepatic and dermal metabolism of 47 cosmetics‐relevant chemicals
Joan Eilstein(L'Oréal (France)), Carine Jacques(Pierre Fabre (France)), Richard Cubberley(Unilever (United Kingdom)), Eric Arbey(L'Oréal (France)), Andreas Schepky(Beiersdorf (Germany)), Sebastien Grégoire(L'Oréal (France)), Corie A. Ellison(Procter & Gamble (United States)), Martina Klarić(Cosmetics Europe), Aurélie Fabre(Inserm), Helga Rothe(Procter & Gamble (Germany)), Camille Géniès(Pierre Fabre (France)), Daniela Lange(MSB Medical School Berlin), Nicola J. Hewitt
Cited by 18
Related Papers
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database
|Nature Genetics|2013|476
Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant
|The American Journal of Human Genetics|2016|265
Effective exposure of chemicals in in vitro cell systems: A review of chemical distribution models
|Toxicology in Vitro|2021|127
Imaging the distribution of skin lipids and topically applied compounds in human skin using mass spectrometry
|Scientific Reports|2018|108
Measurement of the penetration of 56 cosmetic relevant chemicals into and through human skin using a standardized protocol
|Journal of Applied Toxicology|2019|72